Direkt zum Inhalt
Merck
  • Neuropathic mechanisms in the pathophysiology of burns pruritus: redefining directions for therapy and research.

Neuropathic mechanisms in the pathophysiology of burns pruritus: redefining directions for therapy and research.

Journal of burn care & research : official publication of the American Burn Association (2012-11-09)
Ioannis Goutos
ZUSAMMENFASSUNG

Pruritus in burn wounds is a common symptom affecting patient rehabilitation. Over the last decades, there has been a resurgence of interest into more effective strategies to combat this distressing problem; nevertheless, no reports exist in the literature to propose pathophysiological mechanisms responsible for the generation and persistence of pruritic symptoms in the late phases of burns rehabilitation. Neuronal pathways mediating pruritic and painful stimuli share striking similarities, which allows the comparative exploration of the less extensively studied pruritic mechanisms using pain models. Furthermore, emerging anatomical, neurophysiological, and pharmacological evidence supports the involvement of neuropathic mechanisms in chronic burns pruritus. This work updates the conceptual framework for the pathophysiology of burns itch by embracing the contribution of the central nervous system in the maintenance of symptoms into a chronic state. The proposed pathophysiological model paves new avenues in burns pruritus research and is likely to have implications in the quest for more effective therapeutic regimens in clinical practice.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Ondansetron -hydrochlorid Dihydrat, ≥98% (HPLC), powder
Supelco
Ondansetron-Hydrochlorid, Pharmaceutical Secondary Standard; Certified Reference Material
Ondansetron -hydrochlorid Dihydrat, European Pharmacopoeia (EP) Reference Standard
Ondansetron für die TLC-Systemeignung, European Pharmacopoeia (EP) Reference Standard
Ondansetron für die LC-Systemeignung, European Pharmacopoeia (EP) Reference Standard